BPC-157 Reconstitution & Storage: Lab Protocol Guide
Research Use Only: This content is intended for educational and research purposes only. BPC-157 is not approved by the FDA for human use. Not for human or veterinary consumption. For laboratory research use only.
BPC-157 Reconstitution and Storage for Research: A Laboratory Preparation Guide
If you have sourced lyophilized BPC-157 for a research protocol and are ready to prepare it for use, this guide covers the process from start to finish. Proper reconstitution and storage directly affect the quality and consistency of your research outcomes. A compound reconstituted incorrectly — wrong diluent, wrong volume, improper technique — can introduce variables that compromise your data before the first dose is administered in your model.
Researchers sourcing this compound can find BPC-157 research peptide at Palmetto Peptides, available as a ≥98% purity, COA-verified peptide for preclinical laboratory use.
This guide is written for laboratory researchers working with research-grade BPC-157. It is not a guide for human use. BPC-157 is not approved by the FDA for human therapeutic use and is supplied by Palmetto Peptides exclusively for laboratory research purposes.
> Research use only. This guide is for laboratory preparation of BPC-157 in research settings. BPC-157 is not approved by the FDA for human use and is not intended for human administration.
Why Lyophilized BPC-157 Is the Research Standard
Before covering reconstitution, it is worth understanding why lyophilized (freeze-dried) BPC-157 is the standard form for research use — and why pre-mixed solutions should be avoided.
Lyophilization removes water from the peptide through a freeze-drying process that preserves molecular integrity. The result is a stable powder that:
- Remains stable at room temperature during shipping without cold chain requirements
- Has a shelf life of 24 months or more when stored correctly prior to reconstitution
- Allows precise researcher control over reconstitution volume and final concentration
- Matches the form used in the published preclinical literature
Every published preclinical study using injectable BPC-157 has used a form equivalent to freshly reconstituted lyophilized peptide. If you are designing a protocol that references published research parameters, lyophilized is the appropriate starting material.
> Palmetto Peptides BPC-157 — lyophilized powder, third-party COA verified, suitable for all injectable research protocols.
What You Need Before Reconstituting
Gather the following materials before beginning:
Bacteriostatic water (BAC water). This is the appropriate diluent for most BPC-157 research reconstitutions. Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits microbial growth and extends the usable life of the reconstituted solution. Do not use plain sterile water for injection — without a preservative, reconstituted solutions degrade faster and have a shorter usable window. Sterile syringes and needles. Use appropriate gauge needles for both drawing up BAC water and for research administration routes. Common choices for subcutaneous animal research are 25-27 gauge. Alcohol swabs. For wiping vial stoppers before needle insertion to maintain sterility. The BPC-157 vial. Confirm that the lot number on the vial matches the lot number on your COA documentation before proceeding. Do not use product where these do not match. A concentration calculation. Before adding any diluent, determine your target concentration based on your protocol's dose parameters and the quantity in the vial.Concentration Calculation: Getting the Math Right
The most common source of error in peptide reconstitution is adding the wrong volume of diluent without verifying that the resulting concentration is appropriate for the protocol.
Here is a straightforward calculation framework:
Standard example:- Vial contents: 5mg BPC-157
- Diluent volume added: 2mL bacteriostatic water
- Resulting concentration: 2.5mg/mL (2,500µg/mL)
- For a 250µg dose: 0.1mL (10 IU on an insulin syringe)
- For a 500µg dose: 0.2mL (20 IU on an insulin syringe)
- Diluent volume added: 2mL bacteriostatic water
- Resulting concentration: 5mg/mL (5,000µg/mL)
- For a 500µg dose: 0.1mL (10 IU on an insulin syringe)
Choose a diluent volume that produces a concentration allowing practical measurement at your target dose. Very high concentrations require very small measured volumes, which introduces measurement error. Very low concentrations require larger volumes per dose, which may affect model physiology depending on your administration route.
Step-by-Step Reconstitution Protocol
Follow these steps to reconstitute lyophilized BPC-157 correctly:
Step 1 — Verify your materials. Confirm the vial lot number matches your COA. Confirm BAC water is within its use-by date. Confirm all syringes and needles are sterile and in unopened packaging. Step 2 — Calculate your target concentration. Using the framework above, determine how much BAC water to add to achieve your target working concentration. Write this down before proceeding. Step 3 — Wipe the vial stopper. Use an alcohol swab to clean the rubber stopper of the BPC-157 vial. Allow it to dry completely before inserting a needle. Do the same for the BAC water vial if using a multi-dose vial. Step 4 — Draw up the calculated volume of BAC water. Using a sterile syringe, draw up the volume of bacteriostatic water you calculated in Step 2. Step 5 — Inject BAC water into the BPC-157 vial slowly. Insert the needle into the center of the rubber stopper at an angle and inject the BAC water slowly down the side of the vial — not directly onto the lyophilized powder. Injecting directly onto the powder can cause foaming and may degrade the peptide. Step 6 — Swirl gently, do not shake. After adding the BAC water, gently swirl the vial in a circular motion until the powder is fully dissolved. Do not vortex or shake the vial — mechanical agitation can cause peptide aggregation. Step 7 — Confirm full dissolution. The reconstituted solution should be clear and colorless. Any cloudiness, visible particles, or unusual color (yellow or brown tint) should be flagged before proceeding. A slightly cloudy solution may indicate incomplete dissolution or degradation. Step 8 — Label the vial. Record the date of reconstitution on the vial. This is important for tracking the usable window of the solution.Storage: Before and After Reconstitution
Proper storage conditions affect both the shelf life of lyophilized BPC-157 and the usable window of reconstituted solutions.
Lyophilized BPC-157 (Before Reconstitution)
| Storage Condition | Shelf Life | |---|---| | Room temperature, away from light | Stable during shipping and short-term storage | | Refrigerated (2-8°C) | 24+ months | | Freezer (-20°C) | Extended shelf life, appropriate for long-term storage |
Avoid repeated freeze-thaw cycles for lyophilized material, as this can cause degradation over time. Store away from direct light and moisture.
Reconstituted BPC-157 (After Adding BAC Water)
| Storage Condition | Usable Window | |---|---| | Refrigerated (2-8°C) | Up to 4 weeks | | Room temperature | Not recommended; degrade significantly faster | | Frozen after reconstitution | Not recommended; may cause aggregation |
Once reconstituted, BPC-157 in bacteriostatic water should be used within 4 weeks when refrigerated. Label the vial with the reconstitution date and discard after the usable window regardless of remaining volume.
Do not freeze reconstituted BPC-157. Freezing a peptide in aqueous solution can cause ice crystal formation that damages the peptide structure and may cause aggregation upon thawing.
> Shop BPC-157 at Palmetto Peptides — lyophilized, batch-specific COA, available with bacteriostatic water and research supplies.
Common Errors and How to Avoid Them
Using the wrong diluent. Plain sterile water for injection lacks a preservative, which shortens the usable window of reconstituted solutions significantly. Bacteriostatic water is the appropriate choice for multi-dose vials. Some researchers use sterile saline — this is acceptable for single-use preparations but not for multi-dose vials where microbial contamination risk increases with each access. Shaking the vial. Mechanical agitation through shaking can cause peptide aggregation — clumping of peptide molecules — which reduces the concentration of active compound in solution. Always swirl gently rather than shaking. Injecting diluent directly onto the powder. Directing the stream of BAC water directly onto the lyophilized powder can cause foaming, which may trap air in the solution and disrupt dissolution. Aim the stream at the side wall of the vial. Not verifying lot number match. Failing to confirm that the vial lot number matches the COA lot number means you cannot be certain the quality documentation applies to your specific product. Always verify before reconstituting. Ignoring reconstitution date. Without a recorded reconstitution date, there is no reliable way to track whether a solution is within its usable window. Label every vial. Storing reconstituted solution at room temperature. Peptides in aqueous solution degrade significantly faster at room temperature than refrigerated. Refrigerate reconstituted BPC-157 immediately after preparation.For Oral Research Protocols
For researchers studying BPC-157 via oral administration — particularly those studying GI biology where oral route is most mechanistically relevant — Palmetto Peptides carries BPC-157 in capsule form. Oral capsule preparations do not require reconstitution and are formulated for direct use in oral administration research protocols.
> View Palmetto Peptides' oral BPC-157 capsule form — for GI and oral route research protocols.
Summary
Lyophilized BPC-157 reconstituted with bacteriostatic water is the research-standard preparation method. Key steps include verifying COA lot number match, calculating target concentration before adding diluent, adding BAC water slowly down the vial wall, swirling gently rather than shaking, and labeling the vial with reconstitution date. Reconstituted solutions remain usable for up to 4 weeks when refrigerated. Common errors — wrong diluent, shaking the vial, missing lot number verification — can compromise research outcomes before protocols begin. Palmetto Peptides carries BPC-157 in lyophilized injectable and oral capsule forms to support diverse research designs.
For qualified researchers, BPC-157 research peptide is available from Palmetto Peptides with full Certificate of Analysis documentation.
Frequently Asked Questions
What diluent should be used to reconstitute BPC-157 for research? Bacteriostatic water (BAC water) containing 0.9% benzyl alcohol is the appropriate diluent for most BPC-157 research reconstitutions. The benzyl alcohol acts as a preservative that inhibits microbial growth and extends the usable life of the reconstituted solution to approximately 4 weeks when refrigerated. How long is reconstituted BPC-157 stable after preparation? Reconstituted BPC-157 stored in bacteriostatic water and refrigerated at 2-8°C is stable for up to 4 weeks. It should not be stored at room temperature or frozen after reconstitution. How do I calculate the concentration when reconstituting BPC-157? Divide the vial quantity in milligrams by the volume of BAC water added in milliliters. For example: 5mg divided by 2mL equals 2.5mg/mL, or 2,500µg/mL. From this concentration, individual dose volumes can be calculated based on protocol parameters. Why should I not shake the BPC-157 vial after adding diluent? Mechanical agitation through shaking can cause peptide aggregation — clumping of molecules — which reduces the active concentration in solution. Always swirl gently until the powder is fully dissolved. How long does lyophilized BPC-157 last before reconstitution? Properly stored lyophilized BPC-157 — refrigerated at 2-8°C and kept away from light and moisture — has a shelf life of 24 months or more. Freezer storage at -20°C extends this further. Where can I purchase BPC-157 and bacteriostatic water for research? Palmetto Peptides supplies research-grade BPC-157 in lyophilized form along with bacteriostatic water and related research supplies. Visit our BPC-157 product page for current inventory.References
- Chang CH, et al. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." *Journal of Applied Physiology.* 2011;110(3):774–780.
- Jozwiak M, et al. "Multifunctionality and Possible Medical Application of the BPC 157 Peptide." *Pharmaceuticals.* 2025;18(2):185.
- Journal of Peptide Science. "Impact of impurity levels on biological assay validity in peptide research." 2017.
- McGuire F, et al. "Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review." *PMC.* 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12313605/
*Last updated: March 18, 2026* *Author: Palmetto Peptides Research Team* *For research use only. BPC-157 is not approved by the FDA for human use and is not intended for human administration. This guide is for laboratory research preparation purposes only.*
Related Research